CDC authorizes booster shots

Extra shots are now being administered for those who meet the CDC’s requirements.

Myranda New Student Writer

All three COVID-19 vaccines approved by the FDA have now been approved for booster shots. With the rise of the delta variant this summer, infections and hospitalizations increased, even in those who were already vaccinated, considered breakthrough cases. The vaccine companies were already experimenting with booster shots to further society’s immunity, but the presence of the delta variant furthered this purpose with rapid action.

When the first round of vaccine distributions began earlier this year, there was talk that receiving the COVID-19 vaccine would be an annual thing, much like the flu shot, and especially because antibodies for COVID-19 only remain in the body for ninety days. Now, depending on the company, the CDC is recommending getting vaccinated again as early as two months after first vaccinations.

For Pfizer and Moderna, the Center for Disease Controls (CDC) is strongly recommending those who are older than 65, older than 18 with pre-existing conditions and older than 18 in long-term care or high risk settings to get a booster shot six months after they completed their original dosage.

The CDC is recommending anyone older than 18 get their booster shot for the Johnson & Johnson vaccine two months after their original shot.

There is little difference between the shots compared to the ones distributed earlier this year. For Pfizer and Johnson & Johnson, it is the same solution, but for Moderna (whose dosage was three times the amount of Pfizer’s for the same efficiency), the dosage was cut in half.

The side effects are also similar to the original vaccine dosages, including headache, fever and chills. The swollen lymph nodes that may arise from the vaccine are more common with the booster shot than with the first two shots, but for the most part, CDC studies show that the side effects have remained the same. Most importantly,

The booster shots are encouraging to see during the delta variant because while the first vaccines remain effective, as seen from studies done by the CDC this summer, high risk areas and areas of high population concentration are still seeing cases rise. By bringing in booster shots, those infection levels can be brought down again or at least flatten the curve.

The most exciting part of the CDC’s message on booster shots is that they are now authorizing the use of mixing vaccines. If

NPR discussed this phenomenon of mixing vaccines and explained some of the benefits to this method. If your first shot was Johnson & Johnson, it is highly recommended by the CDC to receive an mRNA booster shot by either Pfizer or Moderna so you get the whole of the antibodies. If you received Moderna for your first two shots, you could get Pfizer as your booster shot since it will be a lower dosage.

During the height of the delta variant this past summer, the CDC performed a study on front-line workers and found that vaccines went from 91 percent efficacy to 66 percent efficacy, an efficacy that is still good as it is around the Johnson & Johnson’s vaccine original efficacy. Having these booster shots allows for overall vaccine efficiency to increase while bringing more protection back to communities. NPR goes on to say, “The bottom line, these scientists agree, is that all these ways of boosting your immunity against COVID-19 are safe and effective.”

In relaying her study to NPR, a University of Saskatchewan virologist, Angela Rasmussen, says, “It may just be that you do need this third dose to really lock in that long-lasting durability.” Data is still being collected to understand the extent of the long-term efficiency of booster shots, but vaccinating those in the most high-risk groups and working down the population is a great place to start.

“The side effects are also similar to the original vaccine dosages ...”

courtesy Wikimedia Commons

Patients are encouraged to receive a different booster than their original vaccination.

Oklahoma woman receives prison time for miscarriage

The prosecutor blamed Poolaw’s use of methamphetamine for causing the loss of the fetus.

Maddie Walters

Social Media & Web Manager

Earlier this month, an Oklahoma jury convicted Brittney Poolaw, a 21-year-old member of the Comanche Nation, of first degree manslaughter after suffering a miscarriage, which the prosecution blamed on her use of methamphetamine. Sentenced on Oct. 6, Poolaw, who was only 19 at the time of the miscarriage, received the sentence of four years of jail time in state prison. Poolaw’s conviction has sparked much controversy on social media, garnering support and donations from the National Advocates for Pregnant Women, who has now come to the defense of Poolaw.

Per the medical examiner’s reports, Poolaw was between 15-17 weeks pregnant at the time of her miscarriage, meaning that the fetus had not yet reached viability—the stage at which a fetus can live independently from its mother’s uterus. In the United States, viability does not occur until the fetus reaches 24 weeks of gestational age.

According to the Comanche County District Attorney’s Office, Poolaw’s use of methamphetamine caused the loss of the fetus. Poolaw’s defense said that there is no way to know for certain that her drug use caused the miscarriage. The medical examiner for the case publicly noted the abnormalities present within the fetus; despite these claims, the jury reached their verdict for this case in less than three hours.

Though an autopsy of the fetus showed that it tested positive for the drug, Associated Press, who received a copy of the autopsy report, claims that there is no definitive proof that Poolaw’s drug use caused her miscarriage; AP says that the autopsy shows the miscarriage could have potentially been caused by a congenital abnormality, placental abruption and chorioamnionitis—all of

which was also pointed out at Poolaw’s oneday trial by her lawyers.

The state of Oklahoma alleges that Poolaw violated the state’s manslaughter statute, which defines manslaughter as “When perpetrated without a design to effect death by a person while engaged in the commission of a misdemeanor.” Poolaw’s attorney filed for an appeal on Oct. 15.

The National Advocates for Pregnant Women says that Poolaw’s case is not uncommon. NAPW has documented over 1,600 cases similarly involving the criminalization of a pregnant individual. 57 of these 1,600 cases have occurred in the state of Oklahoma since 2006. In a viral tweet, NAPW said “These cases include pregnant women who have been arrested for falling down stairs, drinking alcohol, giving birth at home, being in a ‘dangerous’ location, having HIV, experiencing a drug dependency problem or attempting suicide. The majority of women subjected to pregnancy-based prosecutions are low-income women, drugusing women, and women of color.”

NAPW has now come to the aid of Poolaw, providing her a new lawyer for her appeal case, rather than the court-appointed attorney from her trial. Her appeal date has not yet been set.

tucollegian@tucollegian.com @TUCOLLEGIAN

“... the jury reached their verdict for this case in less than three hours.”

editor in chief Piper Prolago

managing editor Zach Short

news editor Justin Klopfer

sports editor Logan Guthrie

variety editor Julianne Tran

commentary editor Adam Walsh

satire editor Anna Johns

photo & graphics editor Amy Polovich

business & advertising manager Madeleine Goodman

social media & web manager Maddie Walters

copy editor Ji Aldada

The Collegian is the student newspaper of the University of Tulsa. It is distributed Mondays during the fall and spring semesters, except during holidays and final exam weeks. The University of Tulsa does not discriminate on the basis of personal status or group characteristics including but not limited to the classes protected under federal and state law. Inquiries regarding implementation of this policy may be addressed to the Office of Human Resources, 800 South Tucker Drive, Tulsa, Oklahoma 74104-9700. (918)631-2616. Requests for accomodation of disabilities may be addressed to the university’s 504 Coordinator, Dr. Tawny Rigsby. (918)631-3814. To ensure availability of an interpreter, five to seven days notice is needed; 48 hours is recommended for all other accomodations.

Advertising Policy: Advertising appearing in this publication does not imply approval or endorsement by the University of Tulsa or the Collegian for the products or services advertised. For advertising information, email the Collegian at advertising @tucollegian.org. The deadline for advertising is noon on the Friday prior to publication.

Letter Policy: Letters to the editor must be less than 500 words and can be sent to tucollegian@tucollegian. org. Under no circumstances will anonymous letters be published. The name of the person submitting the letter must be published with the letter. We reserve the right to edit or reject all letters. The deadline for letters is 5 p.m. on the Friday prior to publication.

Editing Policy: The Collegian reserves the right to edit all copy submitted by all writers. This editing my take place in many forms, including grammar corrections, changes in paragraph structure or even the addition or removal of sections of content.

Editorial Policy: Columnists are solely responsible for the content of their columns. Opinions expressed in columns may not represent the opinions of the Collegian staff, the administrative policies of the University of Tulsa, the views of the student body or our advertisers.